Skip to main content
Top
Published in: Annals of General Psychiatry 1/2022

Open Access 01-12-2022 | COVID-19 | Research

COVID-19 outbreak in a psychiatric hospital: what makes it worse?

Authors: Marouan Zoghbi, Chadia Haddad, Wael Khansa, Elie Karam, Angela Chamoun, Dory Hachem

Published in: Annals of General Psychiatry | Issue 1/2022

Login to get access

Abstract

Background

Psychiatric patients could be at risk of worse outcomes from COVID-19 than the general population. The primary objective of the present study was to describe the symptoms and clinical characteristics of COVID-19 patients living in long-term hospital for mental illness in Lebanon. The secondary objective was to evaluate the factors related to COVID-19 disease severity among these patients.

Methods

A retrospective observational study was conducted from September 2020 to January 2021 at the Psychiatric Hospital of the Cross. The total number of COVID‐19 patients in the infected floors is 410 out of 548. The outcome variable was the severity of COVID-19 illness classified into five categories: asymptomatic, mild, moderate, severe and critically ill.

Results

The rate of infection in the affected floors was 74.81%. Almost half of the patients were asymptomatic (49.3%), 43.4% had hyperthermia and only 28.0% had tachycardia and 25.1% developed hypoxia. The multivariate regression analysis showed that higher temperature (ORa = 6.52), lower saturation (ORa = 0.88), higher BMI (ORa = 1.12), higher CRP (ORa = 1.01), being a female (ORa = 4.59), having diabetes (ORa = 8.11) or COPD (ORa = 10.03) were significantly associated with the increase of the COVID-19 severity.

Conclusions

The current study showed that a high rate of infection from COVID-19 was detected in a psychiatric hospital with the majority having asymptomatic to mild symptoms. Female psychiatric patients, desaturation, increase inflammation and comorbidities such as diabetes and COPD were associated with the severity of COVID‐19 among psychiatric patients. Future studies are needed to better understand the causal relation of the factors with severity and long term effects or sequelae of the disease.
Literature
3.
go back to reference Organization WH. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. World Health Organization; 2020. Organization WH. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. World Health Organization; 2020.
4.
go back to reference Xiang Y-T, Zhao Y-J, Liu Z-H, Li X-H, Zhao N, Cheung T, et al. The COVID-19 outbreak and psychiatric hospitals in China: managing challenges through mental health service reform. Int J Biol Sci. 2020;16(10):1741.CrossRef Xiang Y-T, Zhao Y-J, Liu Z-H, Li X-H, Zhao N, Cheung T, et al. The COVID-19 outbreak and psychiatric hospitals in China: managing challenges through mental health service reform. Int J Biol Sci. 2020;16(10):1741.CrossRef
6.
go back to reference Li L. Challenges and priorities in responding to COVID-19 in inpatient psychiatry. Psychiatr Serv. 2020;71:624.CrossRef Li L. Challenges and priorities in responding to COVID-19 in inpatient psychiatry. Psychiatr Serv. 2020;71:624.CrossRef
7.
go back to reference Thakore JH. Metabolic syndrome and schizophrenia. Br J Psychiatry. 2005;186(6):455–6.CrossRef Thakore JH. Metabolic syndrome and schizophrenia. Br J Psychiatry. 2005;186(6):455–6.CrossRef
8.
go back to reference Haddad C, Hallit S, Salameh P, Bou-Assi T, Zoghbi M. Coronary heart disease risk in patients with schizophrenia: a Lebanese cross-sectional study. J Comorb. 2017;7(1):79–88.CrossRef Haddad C, Hallit S, Salameh P, Bou-Assi T, Zoghbi M. Coronary heart disease risk in patients with schizophrenia: a Lebanese cross-sectional study. J Comorb. 2017;7(1):79–88.CrossRef
9.
go back to reference Barnett A, Mackin P, Chaudhry I, Farooqi A, Gadsby R, Heald A, et al. Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia. J Psychopharmacol. 2007;21(4):357–73.CrossRef Barnett A, Mackin P, Chaudhry I, Farooqi A, Gadsby R, Heald A, et al. Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia. J Psychopharmacol. 2007;21(4):357–73.CrossRef
10.
go back to reference O’Reilly K, Donohoe G, Coyle C, O’Sullivan D, Rowe A, Losty M, et al. Prospective cohort study of the relationship between neuro-cognition, social cognition and violence in forensic patients with schizophrenia and schizoaffective disorder. BMC Psychiatry. 2015;15(1):1–17.CrossRef O’Reilly K, Donohoe G, Coyle C, O’Sullivan D, Rowe A, Losty M, et al. Prospective cohort study of the relationship between neuro-cognition, social cognition and violence in forensic patients with schizophrenia and schizoaffective disorder. BMC Psychiatry. 2015;15(1):1–17.CrossRef
11.
go back to reference Wang Q, Xu R, Volkow ND. Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psychiatry. 2021;20(1):124–30.CrossRef Wang Q, Xu R, Volkow ND. Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psychiatry. 2021;20(1):124–30.CrossRef
12.
go back to reference Lee SW, Yang JM, Moon SY, Yoo IK, Ha EK, Kim SY, et al. Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study. Lancet Psychiatry. 2020;7(12):1025–31.CrossRef Lee SW, Yang JM, Moon SY, Yoo IK, Ha EK, Kim SY, et al. Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study. Lancet Psychiatry. 2020;7(12):1025–31.CrossRef
13.
go back to reference Barber S, Reed L, Syam N, Jones N. Severe mental illness and risks from COVID-19. Accessed 3 September 2020. Barber S, Reed L, Syam N, Jones N. Severe mental illness and risks from COVID-19. Accessed 3 September 2020.
16.
go back to reference Karlberg J, Chong D, Lai W. Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? Am J Epidemiol. 2004;159(3):229–31.CrossRef Karlberg J, Chong D, Lai W. Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? Am J Epidemiol. 2004;159(3):229–31.CrossRef
17.
go back to reference Alghamdi IG, Hussain II, Almalki SS, Alghamdi MS, Alghamdi MM, El-Sheemy MA. The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health. Int J General Med. 2014;7:417.CrossRef Alghamdi IG, Hussain II, Almalki SS, Alghamdi MS, Alghamdi MM, El-Sheemy MA. The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health. Int J General Med. 2014;7:417.CrossRef
18.
go back to reference Chen X, Chughtai AA, Dyda A, MacIntyre CR. Comparative epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia and South Korea. Emerg Microb Infect. 2017;6(1):1–6. Chen X, Chughtai AA, Dyda A, MacIntyre CR. Comparative epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia and South Korea. Emerg Microb Infect. 2017;6(1):1–6.
19.
go back to reference Guan W, Liang W, Zhao Y, Liang H, Chen Z, Li Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):200.CrossRef Guan W, Liang W, Zhao Y, Liang H, Chen Z, Li Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):200.CrossRef
20.
go back to reference Jin J-M, Bai P, He W, Wu F, Liu X-F, Han D-M, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020;8:152.CrossRef Jin J-M, Bai P, He W, Wu F, Liu X-F, Han D-M, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020;8:152.CrossRef
21.
go back to reference Klang E, Soffer S, Nadkarni G, Glicksberg B, Freeman R, Horowitz C, et al. Sex differences in age and comorbidities for COVID-19 mortality in urban New York City. SN Comprehensive Clin Med. 2020;2(9):1319–22.CrossRef Klang E, Soffer S, Nadkarni G, Glicksberg B, Freeman R, Horowitz C, et al. Sex differences in age and comorbidities for COVID-19 mortality in urban New York City. SN Comprehensive Clin Med. 2020;2(9):1319–22.CrossRef
22.
go back to reference Vahidy FS, Pan AP, Ahnstedt H, Munshi Y, Choi HA, Tiruneh Y, et al. Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: cross-sectional analysis from a diverse US metropolitan area. PLoS ONE. 2021;16(1): e0245556.CrossRef Vahidy FS, Pan AP, Ahnstedt H, Munshi Y, Choi HA, Tiruneh Y, et al. Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: cross-sectional analysis from a diverse US metropolitan area. PLoS ONE. 2021;16(1): e0245556.CrossRef
23.
go back to reference Chakravarty D, Nair SS, Hammouda N, Ratnani P, Gharib Y, Wagaskar V, et al. Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer. Communications Biol. 2020;3(1):1–12.CrossRef Chakravarty D, Nair SS, Hammouda N, Ratnani P, Gharib Y, Wagaskar V, et al. Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer. Communications Biol. 2020;3(1):1–12.CrossRef
24.
go back to reference Meng Y, Wu P, Lu W, Liu K, Ma K, Huang L, et al. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: a retrospective study of 168 severe patients. PLoS Pathog. 2020;16(4): e1008520.CrossRef Meng Y, Wu P, Lu W, Liu K, Ma K, Huang L, et al. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: a retrospective study of 168 severe patients. PLoS Pathog. 2020;16(4): e1008520.CrossRef
26.
go back to reference Su W, Qiu Z, Zhou L, Hou J, Wang Y, Huang F, et al. Sex differences in clinical characteristics and risk factors for mortality among severe patients with COVID-19: a retrospective study. Aging (Albany NY). 2020;12(19):18833.CrossRef Su W, Qiu Z, Zhou L, Hou J, Wang Y, Huang F, et al. Sex differences in clinical characteristics and risk factors for mortality among severe patients with COVID-19: a retrospective study. Aging (Albany NY). 2020;12(19):18833.CrossRef
27.
go back to reference Rajkumar RP. COVID-19 and mental health: a review of the existing literature. Asian J Psychiatr. 2020;52: 102066.CrossRef Rajkumar RP. COVID-19 and mental health: a review of the existing literature. Asian J Psychiatr. 2020;52: 102066.CrossRef
29.
go back to reference Thompson JW Jr, Mikolajewski AJ, Kissinger P, McCrossen P, Smither A, Chamarthi GD, et al. An epidemiologic study of COVID-19 patients in a state psychiatric hospital: high penetrance with early CDC guidelines. Psychiatr Serv. 2020;71(12):1285–7.CrossRef Thompson JW Jr, Mikolajewski AJ, Kissinger P, McCrossen P, Smither A, Chamarthi GD, et al. An epidemiologic study of COVID-19 patients in a state psychiatric hospital: high penetrance with early CDC guidelines. Psychiatr Serv. 2020;71(12):1285–7.CrossRef
30.
go back to reference NI Health. Coronavirus disease 2019 (COVID-19) treatment guidelines. Bethesda: NIH; 2020. NI Health. Coronavirus disease 2019 (COVID-19) treatment guidelines. Bethesda: NIH; 2020.
31.
go back to reference Khalil A, Feghali R, Hassoun M. The Lebanese Cohort for COVID-19; A challenge for the ABO blood group system. Frontiers in Medicine 7 (2020): 585341.CrossRef Khalil A, Feghali R, Hassoun M. The Lebanese Cohort for COVID-19; A challenge for the ABO blood group system. Frontiers in Medicine 7 (2020): 585341.CrossRef
32.
go back to reference Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583(7816):459–68.CrossRef Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583(7816):459–68.CrossRef
33.
go back to reference Li J, He X, Yuan Y, Zhang W, Li X, Zhang Y, et al. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia. Am J Infect Control. 2021;49(1):82–9.CrossRef Li J, He X, Yuan Y, Zhang W, Li X, Zhang Y, et al. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia. Am J Infect Control. 2021;49(1):82–9.CrossRef
34.
go back to reference Zheng X, Chen J, Deng L, Fang Z, Chen G, Ye D, et al. Risk factors for the COVID-19 severity and its correlation with viral shedding: a retrospective cohort study. J Med Virol. 2021;93(2):952–61.CrossRef Zheng X, Chen J, Deng L, Fang Z, Chen G, Ye D, et al. Risk factors for the COVID-19 severity and its correlation with viral shedding: a retrospective cohort study. J Med Virol. 2021;93(2):952–61.CrossRef
35.
go back to reference Chu Y, Yang J, Shi J, Zhang P, Wang X. Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis. Eur J Med Res. 2020;25(1):1–15.CrossRef Chu Y, Yang J, Shi J, Zhang P, Wang X. Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis. Eur J Med Res. 2020;25(1):1–15.CrossRef
37.
go back to reference Gadi N, Wu SC, Spihlman AP, Moulton VR. What’s sex got to do with COVID-19? Gender-based differences in the host immune response to coronaviruses. Front Immunol. 2020;11:2147.CrossRef Gadi N, Wu SC, Spihlman AP, Moulton VR. What’s sex got to do with COVID-19? Gender-based differences in the host immune response to coronaviruses. Front Immunol. 2020;11:2147.CrossRef
38.
go back to reference Kopel J, Perisetti A, Roghani A, Aziz M, Gajendran M, Goyal H. Racial and gender-based differences in COVID-19. Front Public Health. 2020;8:418.CrossRef Kopel J, Perisetti A, Roghani A, Aziz M, Gajendran M, Goyal H. Racial and gender-based differences in COVID-19. Front Public Health. 2020;8:418.CrossRef
41.
go back to reference Fernández-de-Las-Peñas C, Martín-Guerrero JD, Pellicer-Valero ÓJ, Navarro-Pardo E, Gómez-Mayordomo V, Cuadrado ML, et al. Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: the LONG-COVID-EXP-CM multicenter study. J Clin Med. 2022;11(2):413.CrossRef Fernández-de-Las-Peñas C, Martín-Guerrero JD, Pellicer-Valero ÓJ, Navarro-Pardo E, Gómez-Mayordomo V, Cuadrado ML, et al. Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: the LONG-COVID-EXP-CM multicenter study. J Clin Med. 2022;11(2):413.CrossRef
42.
go back to reference Yang H, Chen W, Hu Y, Chen Y, Zeng Y, Sun Y, et al. Pre-pandemic psychiatric disorders and risk of COVID-19: a cohort analysis in the UK Biobank. medRxiv. 2020;91:157. Yang H, Chen W, Hu Y, Chen Y, Zeng Y, Sun Y, et al. Pre-pandemic psychiatric disorders and risk of COVID-19: a cohort analysis in the UK Biobank. medRxiv. 2020;91:157.
43.
go back to reference Canal-Rivero M, Barragán RC, García AR, Torres NG, Crespo-Facorro B, Ruiz-Veguilla M, et al. Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: a retrospective epidemiological study in a representative Spanish population. Schizophr Res. 2021;229:53.CrossRef Canal-Rivero M, Barragán RC, García AR, Torres NG, Crespo-Facorro B, Ruiz-Veguilla M, et al. Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: a retrospective epidemiological study in a representative Spanish population. Schizophr Res. 2021;229:53.CrossRef
44.
go back to reference McKeigue PM, Kennedy S, Weir A, Bishop J, McGurnaghan SJ, McAllister D, et al. Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study. BMC Med. 2021;19(1):1–11.CrossRef McKeigue PM, Kennedy S, Weir A, Bishop J, McGurnaghan SJ, McAllister D, et al. Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study. BMC Med. 2021;19(1):1–11.CrossRef
45.
go back to reference Bilbul M, Paparone P, Kim AM, Mutalik S, Ernst CL. Psychopharmacology of COVID-19. Psychosomatics. 2020;61(5):411–27.CrossRef Bilbul M, Paparone P, Kim AM, Mutalik S, Ernst CL. Psychopharmacology of COVID-19. Psychosomatics. 2020;61(5):411–27.CrossRef
46.
go back to reference Dratcu L, Boland X. Can antipsychotic use protect from COVID-19? Schizophr Res. 2021;236:1.CrossRef Dratcu L, Boland X. Can antipsychotic use protect from COVID-19? Schizophr Res. 2021;236:1.CrossRef
47.
go back to reference Kuroda N. Epilepsy and COVID-19: associations and important considerations. Epilepsy Behav. 2020;108:107122.CrossRef Kuroda N. Epilepsy and COVID-19: associations and important considerations. Epilepsy Behav. 2020;108:107122.CrossRef
Metadata
Title
COVID-19 outbreak in a psychiatric hospital: what makes it worse?
Authors
Marouan Zoghbi
Chadia Haddad
Wael Khansa
Elie Karam
Angela Chamoun
Dory Hachem
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Annals of General Psychiatry / Issue 1/2022
Electronic ISSN: 1744-859X
DOI
https://doi.org/10.1186/s12991-022-00403-4

Other articles of this Issue 1/2022

Annals of General Psychiatry 1/2022 Go to the issue